Financhill
Back

Swedish Orphan Biovitrum AB Quote, Financials, Valuation and Earnings

The dark truth about AI

Click here to learn more...
Buy
66

SWOBY
Swedish Orphan Biovitrum AB

Last Price:
15.00
Seasonality Move:
0.77%

7 Day Trial

ALL ACCESS PASS

$ 7

Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!

Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)

Swedish Orphan Biovitrum AB Price Quote

$15.00

Swedish Orphan Biovitrum AB Key Stats

Buy
66
Swedish Orphan Biovitrum AB (SWOBY) is a Buy

Day range:
$15.00 - $15.00
52-week range:
$12.03 - $17.20
Dividend yield:
0%
P/E ratio:
40.19
P/S ratio:
4.04
P/B ratio:
2.62%

Volume:
100
Avg. volume:
631
1-year change:
24.87%
Market cap:
$9.6B
Revenue:
$2.1B
EPS:
$0.49

How Much Does Swedish Orphan Biovitrum AB Make?

Is Swedish Orphan Biovitrum AB Growing As A Company?

Swedish Orphan Biovitrum AB Stock Price Performance

What Is Swedish Orphan Biovitrum AB 52-Week High & Low?

Swedish Orphan Biovitrum AB Price To Free Cash Flow

Is It Risky To Buy Swedish Orphan Biovitrum AB?

Is Swedish Orphan Biovitrum AB Cash Flow Positive?

  • What Is SWOBY Cash Flow From Operations?
    Cash flow from operations (TTM) is $646M
  • What Is Swedish Orphan Biovitrum AB’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$278.2M
  • What Is Swedish Orphan Biovitrum AB’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$368.9M

Swedish Orphan Biovitrum AB Return On Invested Capital

  • Is Management Doing A Good Job?
    SWOBY return on invested capital is 6.46%
  • What Is Swedish Orphan Biovitrum AB Return On Assets?
    ROA measures how assets are converting to revenues and is 4.75%
  • What Is SWOBY Return On Equity?
    ROE is a measure of profitability and is 9.88%

Swedish Orphan Biovitrum AB Earnings Date & Stock Price

Swedish Orphan Biovitrum AB Competitors

Swedish Orphan Biovitrum AB Dividend Yield

Swedish Orphan Biovitrum AB Analyst Estimates

YoY Growth Past Surprise
EPS: 1362.12% 0%
Revenue: 38.66% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable